Table 1.
Patient demographics
| Group | Patient number | Age | Sex | CRP (mg/dl) | ESR (mm) | Medicine | ||
|---|---|---|---|---|---|---|---|---|
| PSL (mg/day) | DMARDs other than biologics | Biologics | ||||||
| RA | #1 | 62 | F | 0.05 | 46 | MTX | ADA | |
| #2 | 67 | F | 0.49 | 29 | MTX | |||
| #3 | 43 | F | 0.2 | 26 | 2 | MTX | ||
| #4 | 48 | F | 0.06 | 39 | ||||
| #5 | 42 | F | 0.3 | 15 | 16 | MTX | GLM | |
| #6 | 80 | F | 4.2 | 71 | TCR, SASP, BUC | |||
| #7 | 76 | M | 5.9 | 111 | MTX | |||
| #8 | 62 | F | 0.5 | 38 | ||||
| OA | #9 | 66 | F | 0.02 | 10 | |||
| #10 | 72 | F | 0.42 | 28 | ||||
| #11 | 75 | F | 0.07 | 14 | ||||
| #12 | 74 | F | 0.1 | 40 | ||||
| #13 | 74 | F | 0.03 | 9 | ||||
| #14 | 71 | F | 0.02 | 14 | ||||
| #15 | 78 | F | 0.12 | 18 | ||||
| #16 | 81 | F | 0.03 | 18 | ||||
Male vs. female was 1:7 in the RA group and 0:8 in the OA group, showing no significant difference (p = 0.99 by Mann-Whitney’s U test). The mean of age was 60 years old in the RA group, and 74 years old in the OA group: no significant difference between them (p = 0.06 by Mann-Whitney’s U test)
CRP C-reactive protein, ESR erythrocyte sedimentation rate, PSL prednisolone, DMARDS disease-modifying antirheumatic drugs, MTX methotrexate, RA rheumatoid arthritis, ADA adalimumab, GLM golimumab, TCR tacrolimus,, SASP salazosulfapyridine, BUC bucillamine, OA osteoarthritis